Aims: The aim of the study was to characterize e-cigarette users in terms of their consumption patterns, motives, and the perceived health benefits they experience from using e-cigarettes. Design: The study was a cross-sectional online survey in 2015. A total of 3,320 German e-cigarette users were enrolled. A total of 91.5% were former tobacco smokers, 7.5% used both e-cigarettes and tobacco products, 1.0% were never-smokers. Results: No differences were found between ex-smokers and dual users with regard to sociodemographic and smoking history (mean age 40.8 years, 81% men, 45% with a high school degree or above). Both groups had smoked 26.4 tobacco cigarettes a day for 22 years, had unsuccessfully tried to quit smoking using various other nicotine replacement products, and had used e-cigarettes for an average of 2 years. Ex-smokers consumed lower nicotine strength and more liquid per month, experienced more positive health changes, and had made vaping their hobby. Never-smokers were about 5 years younger, used liquid without nicotine and without tobacco flavor, and had no physical dependency. Conclusions: E-cigarettes were primarily used as an alternative to smoking and a substitute for nicotine. More dual users than ex-smokers used e-cigarettes in places where smoking is forbidden. Positive health changes were more pronounced in ex-smokers than dual users.

Keywords:
Electronic cigarettes, Electronic nicotine delivery system, Vaping, Harm reduction, Use pattern, Health, Germany, Survey
1.
Dawkins L, Turner J, Roberts A, Soar K: ‘Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 2013;108:1115-1125.
2.
Etter JF: Explaining the effects of electronic cigarettes on craving for tobacco in recent quitters. Drug Alcohol Depend 2015;148:102-108.
3.
Hajek P, McRobbie H, Gillison F: Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user. Prev Med 2007;44:230-234.
4.
Wagener TL, Floyd EL, Stepanov I, Driskill LM, Frank SG, Meier E, Leavens EL, Tackett AP, Molina N, Queimado L: Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control 2017;26:e23-e28.
5.
Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, Lee M: Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014;23(suppl 3):iii3-iii9.
6.
Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Voudris V: Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Environ Res Public Health 2013;10:7272-7282.
7.
Etter JF, Bullen C: Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011;106:2017-2028.
8.
Cobb NK, Byron MJ, Abrams DB, Shields PG: Novel nicotine delivery systems and public health: the rise of the “e-cigarette”. Am J Public Health 2010;100:2340-2342.
9.
Cobb CO, Hendricks PS, Eissenberg T: Electronic cigarettes and nicotine dependence: evolving products, evolving problems. BMC Med 2015;13:119.
10.
Williams M, Talbot P: Variability among electronic cigarettes in the pressure drop, airflow rate, and aerosol production. Nicotine Tob Res 2011;13:1276-1283.
11.
Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P: Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013;8:e57987.
12.
Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Jacob P 3rd, Benowitz N: Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133-139.
13.
Adkison SE, O'Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, Cummings KM, McNeill A, Thrasher JF, Hammond D, Fong GT: Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med 2013;44:207-215.
14.
Choi K, Forster J: Characteristics associated with awareness, perceptions, and use of electronic nicotine delivery systems among young us midwestern adults. Am J Public Health 2013;103:556-561.
15.
Schneider S, Görig T, Diehl K: Die e-zigarette - bundesweite daten zu bekanntheit, nutzung und risikowahrnehmung. ASU Arbeitsmed Sozialmed Umweltmed 2015;50:818-823.
16.
Eastwood B, Dockrell MJ, Arnott D, Britton J, Cheeseman H, Jarvis MJ, McNeill A: Electronic cigarette use in young people in Great Britain 2013-2014. Public Health 2015;129:1150-1156.
17.
Hummel K, Hoving C, Nagelhout GE, de Vries H, van den Putte B, Candel MJ, Borland R, Willemsen MC: Prevalence and reasons for use of electronic cigarettes among smokers: findings from the international tobacco control (ITC) Netherlands survey. Int J Drug Policy 2015;26:601-608.
18.
Brown J, West R, Beard E, Michie S, Shahab L, McNeill A: Prevalence and characteristics of e-cigarette users in Great Britain: findings from a general population survey of smokers. Addict Behav 2014;39:1120-1125.
19.
Dockrell M, Morrison R, Bauld L, McNeill A: E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 2013;15:1737-1744.
20.
Giovenco DP, Lewis MJ, Delnevo CD: Factors associated with e-cigarette use: a national population survey of current and former smokers. Am J Prev Med 2014;47:476-480.
21.
Goniewicz ML, Zielinska-Danch W: Electronic cigarette use among teenagers and young adults in Poland. Pediatrics 2012;130:e879-e885.
22.
Andler R, Guignard R, Wilquin JL, Beck F, Richard JB, Nguyen-Thanh V: Electronic cigarette use in France in 2014. Int J Public Health 2015;61:159-165.
23.
Vardavas CI, Filippidis FT, Agaku IT: Determinants and prevalence of e-cigarette use throughout the European union: a secondary analysis of 26 566 youth and adults from 27 countries. Tob Control 2015;24:442-448.
24.
Farsalinos KE, Poulas K, Voudris V, Le Houezec J: Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction 2016;111:2032-2040.
25.
Beard E, West R, Michie S, Brown J: Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends. BMJ 2016;354:i4645.
26.
Brown J, Beard E, Kotz D, Michie S, West R: Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014;109:1531-1540.
27.
Christensen T, Welsh E, Faseru B: Profile of e-cigarette use and its relationship with cigarette quit attempts and abstinence in Kansas adults. Prev Med 2014;69:90-94.
28.
Pepper JK, Ribisl KM, Emery SL, Brewer NT: Reasons for starting and stopping electronic cigarette use. Int J Environ Res Public Health 2014;11:10345-10361.
29.
Etter JF: Electronic cigarettes: a survey of users. BMC Public Health 2010;10:231.
30.
Goniewicz ML, Lingas EO, Hajek P: Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. Drug Alcohol Rev 2013;32:133-140.
31.
Harrell PT, Marquinez NS, Correa JB, Meltzer LR, Unrod M, Sutton SK, Simmons VN, Brandon TH: Expectancies for cigarettes, e-cigarettes, and nicotine replacement therapies among e-cigarette users (aka vapers). Nicotine Tob Res 2015;17:193-200.
32.
Volesky KD, Maki A, Scherf C, Watson LM, Cassol E, Villeneuve PJ: Characteristics of e-cigarette users and their perceptions of the benefits, harms and risks of e-cigarette use: survey results from a convenience sample in Ottawa, Canada. Health Promot Chronic Dis Prev Can 2016;36:130-138.
33.
Royal College of Physicians: Nicotine without Smoke: Tobacco Harm Reduction. London, RCP, 2016.
34.
Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V: Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health 2014;11:4356-4373.
35.
McQueen A, Tower S, Sumner W: Interviews with “vapers”: implications for future research with electronic cigarettes. Nicotine Tob Res 2011;13:860-867.
36.
Rüther T, Wissen F, Linhardt A, Aichert DS, Pogarell O, de Vries H: Electronic cigarettes - attitudes and use in Germany. Nicotine Tob Res 2015;18:1-10.
37.
Pepper JK, Byron MJ, Ribisl KM, Brewer NT: How hearing about harmful chemicals affects smokers' interest in dual use of cigarettes and e-cigarettes. Prev Med 2017;96:144-148.
38.
Levy DT, Borland R, Villanti AC, Niaura R, Yuan Z, Zhang Y, Meza R, Holford TR, Fong GT, Cummings KM, Abrams DB: The application of a decision-theoretic model to estimate the public health impact of vaporized nicotine product initiation in the united states. Nicotine Tob Res 2017;19:149-159.
39.
Etter JF, Bullen C: Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011;106:2017-2028.
40.
Sussman S, Allem JP, Garcia J, Unger JB, Cruz TB, Garcia R, Baezconde-Garbanati L: Who walks into vape shops in Southern California?: a naturalistic observation of customers. Tob Induc Dis 2016;14:18
41.
Emery SL, Vera L, Huang J, Szczypka G: Wanna know about vaping? Patterns of message exposure, seeking and sharing information about e-cigarettes across media platforms. Tob Control 2014;23:17-25.
42.
Etter JF: Characteristics of users and usage of different types of electronic cigarettes: findings from an online survey. Addiction 2016;111:724-733.
43.
Dawkins L, Corcoran O: Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) 2014;231:401-407.
44.
Dawkins L, Turner J, Hasna S, Soar K: The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav 2012;37:970-973.
45.
Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L: E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One 2015;10:e0122544
46.
Biener L, Hargraves JL: A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res 2015;17:127-133.
47.
Brose LS, Hitchman SC, Brown J, West R, McNeill A: Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction 2015;110:1160-1168.
48.
Campagna D, Cibella F, Caponnetto P, Amaradio MD, Caruso M, Morjaria JB, Malerba M, Polosa R: Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. Eur J Clin Invest 2016;46:698-706.
49.
Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H: Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014;109:1801-1810.
50.
Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D: Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 2014;20:218-225.
51.
McNeill A, Brose L, Calder R, Hitchman S, Hajek P, McRobbie H: E-Cigarettes: An Evidence Update. Public Health England, 2015.
52.
Shahab L, Goniewicz ML, Blount BC, Brown J, McNeill A, Alwis KU, Feng J, Wang L, West R: Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional Study. Ann Intern Med 2017;166:390-400.
53.
Piñeiro B, Correa JB, Simmons VN, Harrell PT, Menzie NS, Unrod M, Meltzer LR, Brandon TH: Gender differences in use and expectancies of e-cigarettes: Online survey results. Addict Behav 2016;52:91-97.
54.
Foulds J, Veldheer S, Yingst J, Hrabovsky S, Wilson SJ, Nichols TT, Eissenberg T: Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking e-cigarette users. Nicotine Tob Res 2015;17:186-192.
55.
Cobb NK, Abrams DB: E-cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med 2011;365:193-195.
56.
Hughes JR, Shiffman S, Callas P, Zhang J: A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 2003;12:21-27.
57.
Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;11:CD000146.
58.
(AWMF) AdWMF: S3-leitlinie ‘screening, diagnostik und behandlung des schädlichen und abhängigen tabakkonsums'. AWMF online 2015;AWMF-Register Nr. 076-006
59.
Borland R: Electronic cigarettes as a method of tobacco control. BMJ 2011;343:d6269
60.
Cahn Z, Siegel M: Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy 2011;32:16-31.
61.
Schaller K, Mons U: E-shishas und e-zigaretten: debatte um schaden und nutzen. Dtsch Arztebl 2017;114:A-70/B-62/C-62.
62.
Barbeau AM, Burda J, Siegel M: Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract 2013;8:5.
63.
Action on Smoking and Health: Use of Electronic Cigarettes (Vapourisers) among Adults in Great Britain, 2016.
64.
Hajek P, Przulj D, Phillips A, Anderson R, McRobbie H: Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology (Berl) 2017;234:773-779.
65.
Hitchman SC, Brose LS, Brown J, Robson D, McNeill A: Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine Tob Res 2015;17:1187-1194.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.